Medical Care
Global Geographic Atrophy Treatment Market Research Report 2024
- Aug 28, 24
- ID: 515318
- Pages: 83
- Figures: 163
- Views: 2
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
The global Geographic Atrophy Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy Treatment.
Report Scope
The Geographic Atrophy Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geographic Atrophy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geographic Atrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Segment by Type
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geographic Atrophy Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Geographic Atrophy Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy Treatment.
Report Scope
The Geographic Atrophy Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geographic Atrophy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geographic Atrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Segment by Type
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geographic Atrophy Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Late-stage (Phase III) Treatment
1.2.3 Phase II Treatment
1.2.4 Phase I Treatment
1.2.5 Pre-Clinical Stage Treatment
1.3 Market by Application
1.3.1 Global Geographic Atrophy Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Treatment Market Perspective (2019-2030)
2.2 Geographic Atrophy Treatment Growth Trends by Region
2.2.1 Global Geographic Atrophy Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Geographic Atrophy Treatment Historic Market Size by Region (2019-2024)
2.2.3 Geographic Atrophy Treatment Forecasted Market Size by Region (2025-2030)
2.3 Geographic Atrophy Treatment Market Dynamics
2.3.1 Geographic Atrophy Treatment Industry Trends
2.3.2 Geographic Atrophy Treatment Market Drivers
2.3.3 Geographic Atrophy Treatment Market Challenges
2.3.4 Geographic Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geographic Atrophy Treatment Players by Revenue
3.1.1 Global Top Geographic Atrophy Treatment Players by Revenue (2019-2024)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Geographic Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geographic Atrophy Treatment Revenue
3.4 Global Geographic Atrophy Treatment Market Concentration Ratio
3.4.1 Global Geographic Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Treatment Revenue in 2023
3.5 Geographic Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Geographic Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Geographic Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Treatment Breakdown Data by Type
4.1 Global Geographic Atrophy Treatment Historic Market Size by Type (2019-2024)
4.2 Global Geographic Atrophy Treatment Forecasted Market Size by Type (2025-2030)
5 Geographic Atrophy Treatment Breakdown Data by Application
5.1 Global Geographic Atrophy Treatment Historic Market Size by Application (2019-2024)
5.2 Global Geographic Atrophy Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Geographic Atrophy Treatment Market Size (2019-2030)
6.2 North America Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Geographic Atrophy Treatment Market Size by Country (2019-2024)
6.4 North America Geographic Atrophy Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geographic Atrophy Treatment Market Size (2019-2030)
7.2 Europe Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Geographic Atrophy Treatment Market Size by Country (2019-2024)
7.4 Europe Geographic Atrophy Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geographic Atrophy Treatment Market Size (2019-2030)
8.2 Asia-Pacific Geographic Atrophy Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geographic Atrophy Treatment Market Size (2019-2030)
9.2 Latin America Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Geographic Atrophy Treatment Market Size by Country (2019-2024)
9.4 Latin America Geographic Atrophy Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geographic Atrophy Treatment Market Size (2019-2030)
10.2 Middle East & Africa Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Detail
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.1.5 Apellis Pharmaceuticals Recent Development
11.2 IVERIC bio
11.2.1 IVERIC bio Company Detail
11.2.2 IVERIC bio Business Overview
11.2.3 IVERIC bio Geographic Atrophy Treatment Introduction
11.2.4 IVERIC bio Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.2.5 IVERIC bio Recent Development
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Detail
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.3.5 Alkeus Pharmaceuticals Recent Development
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Detail
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.4.5 Hemera Biosciences Recent Development
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Detail
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.5.5 Allegro Ophthalmics Recent Development
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Detail
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.6.5 Stealth BioTherapeutics Recent Development
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Detail
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.7.5 Gyroscope Therapeutics Recent Development
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Detail
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.8.5 Regenerative Patch Technologies Recent Development
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Detail
11.9.2 Roche Holding AG Business Overview
11.9.3 Roche Holding AG Geographic Atrophy Treatment Introduction
11.9.4 Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.9.5 Roche Holding AG Recent Development
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Detail
11.10.2 Gensight Biologics SA Business Overview
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Introduction
11.10.4 Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.10.5 Gensight Biologics SA Recent Development
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Detail
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.11.5 NGM Biopharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Treatment Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.12.5 AstraZeneca Recent Development
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Detail
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.13.5 Lineage Cell Therapeutics Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Treatment Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Late-stage (Phase III) Treatment
1.2.3 Phase II Treatment
1.2.4 Phase I Treatment
1.2.5 Pre-Clinical Stage Treatment
1.3 Market by Application
1.3.1 Global Geographic Atrophy Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Treatment Market Perspective (2019-2030)
2.2 Geographic Atrophy Treatment Growth Trends by Region
2.2.1 Global Geographic Atrophy Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Geographic Atrophy Treatment Historic Market Size by Region (2019-2024)
2.2.3 Geographic Atrophy Treatment Forecasted Market Size by Region (2025-2030)
2.3 Geographic Atrophy Treatment Market Dynamics
2.3.1 Geographic Atrophy Treatment Industry Trends
2.3.2 Geographic Atrophy Treatment Market Drivers
2.3.3 Geographic Atrophy Treatment Market Challenges
2.3.4 Geographic Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geographic Atrophy Treatment Players by Revenue
3.1.1 Global Top Geographic Atrophy Treatment Players by Revenue (2019-2024)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Geographic Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geographic Atrophy Treatment Revenue
3.4 Global Geographic Atrophy Treatment Market Concentration Ratio
3.4.1 Global Geographic Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Treatment Revenue in 2023
3.5 Geographic Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Geographic Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Geographic Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Treatment Breakdown Data by Type
4.1 Global Geographic Atrophy Treatment Historic Market Size by Type (2019-2024)
4.2 Global Geographic Atrophy Treatment Forecasted Market Size by Type (2025-2030)
5 Geographic Atrophy Treatment Breakdown Data by Application
5.1 Global Geographic Atrophy Treatment Historic Market Size by Application (2019-2024)
5.2 Global Geographic Atrophy Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Geographic Atrophy Treatment Market Size (2019-2030)
6.2 North America Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Geographic Atrophy Treatment Market Size by Country (2019-2024)
6.4 North America Geographic Atrophy Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geographic Atrophy Treatment Market Size (2019-2030)
7.2 Europe Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Geographic Atrophy Treatment Market Size by Country (2019-2024)
7.4 Europe Geographic Atrophy Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geographic Atrophy Treatment Market Size (2019-2030)
8.2 Asia-Pacific Geographic Atrophy Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geographic Atrophy Treatment Market Size (2019-2030)
9.2 Latin America Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Geographic Atrophy Treatment Market Size by Country (2019-2024)
9.4 Latin America Geographic Atrophy Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geographic Atrophy Treatment Market Size (2019-2030)
10.2 Middle East & Africa Geographic Atrophy Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Detail
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.1.5 Apellis Pharmaceuticals Recent Development
11.2 IVERIC bio
11.2.1 IVERIC bio Company Detail
11.2.2 IVERIC bio Business Overview
11.2.3 IVERIC bio Geographic Atrophy Treatment Introduction
11.2.4 IVERIC bio Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.2.5 IVERIC bio Recent Development
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Detail
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.3.5 Alkeus Pharmaceuticals Recent Development
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Detail
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.4.5 Hemera Biosciences Recent Development
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Detail
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.5.5 Allegro Ophthalmics Recent Development
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Detail
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.6.5 Stealth BioTherapeutics Recent Development
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Detail
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.7.5 Gyroscope Therapeutics Recent Development
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Detail
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.8.5 Regenerative Patch Technologies Recent Development
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Detail
11.9.2 Roche Holding AG Business Overview
11.9.3 Roche Holding AG Geographic Atrophy Treatment Introduction
11.9.4 Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.9.5 Roche Holding AG Recent Development
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Detail
11.10.2 Gensight Biologics SA Business Overview
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Introduction
11.10.4 Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.10.5 Gensight Biologics SA Recent Development
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Detail
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.11.5 NGM Biopharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Treatment Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.12.5 AstraZeneca Recent Development
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Detail
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.13.5 Lineage Cell Therapeutics Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Treatment Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Treatment Business (2019-2024)
11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Geographic Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Late-stage (Phase III) Treatment
Table 3. Key Players of Phase II Treatment
Table 4. Key Players of Phase I Treatment
Table 5. Key Players of Pre-Clinical Stage Treatment
Table 6. Global Geographic Atrophy Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Geographic Atrophy Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Geographic Atrophy Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Geographic Atrophy Treatment Market Share by Region (2019-2024)
Table 10. Global Geographic Atrophy Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Geographic Atrophy Treatment Market Share by Region (2025-2030)
Table 12. Geographic Atrophy Treatment Market Trends
Table 13. Geographic Atrophy Treatment Market Drivers
Table 14. Geographic Atrophy Treatment Market Challenges
Table 15. Geographic Atrophy Treatment Market Restraints
Table 16. Global Geographic Atrophy Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Geographic Atrophy Treatment Market Share by Players (2019-2024)
Table 18. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2023)
Table 19. Ranking of Global Top Geographic Atrophy Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Geographic Atrophy Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Geographic Atrophy Treatment Product Solution and Service
Table 23. Date of Enter into Geographic Atrophy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Geographic Atrophy Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Geographic Atrophy Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Geographic Atrophy Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Geographic Atrophy Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Geographic Atrophy Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Geographic Atrophy Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Geographic Atrophy Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Geographic Atrophy Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Geographic Atrophy Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Apellis Pharmaceuticals Company Detail
Table 49. Apellis Pharmaceuticals Business Overview
Table 50. Apellis Pharmaceuticals Geographic Atrophy Treatment Product
Table 51. Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 52. Apellis Pharmaceuticals Recent Development
Table 53. IVERIC bio Company Detail
Table 54. IVERIC bio Business Overview
Table 55. IVERIC bio Geographic Atrophy Treatment Product
Table 56. IVERIC bio Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 57. IVERIC bio Recent Development
Table 58. Alkeus Pharmaceuticals Company Detail
Table 59. Alkeus Pharmaceuticals Business Overview
Table 60. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product
Table 61. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 62. Alkeus Pharmaceuticals Recent Development
Table 63. Hemera Biosciences Company Detail
Table 64. Hemera Biosciences Business Overview
Table 65. Hemera Biosciences Geographic Atrophy Treatment Product
Table 66. Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 67. Hemera Biosciences Recent Development
Table 68. Allegro Ophthalmics Company Detail
Table 69. Allegro Ophthalmics Business Overview
Table 70. Allegro Ophthalmics Geographic Atrophy Treatment Product
Table 71. Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 72. Allegro Ophthalmics Recent Development
Table 73. Stealth BioTherapeutics Company Detail
Table 74. Stealth BioTherapeutics Business Overview
Table 75. Stealth BioTherapeutics Geographic Atrophy Treatment Product
Table 76. Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 77. Stealth BioTherapeutics Recent Development
Table 78. Gyroscope Therapeutics Company Detail
Table 79. Gyroscope Therapeutics Business Overview
Table 80. Gyroscope Therapeutics Geographic Atrophy Treatment Product
Table 81. Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 82. Gyroscope Therapeutics Recent Development
Table 83. Regenerative Patch Technologies Company Detail
Table 84. Regenerative Patch Technologies Business Overview
Table 85. Regenerative Patch Technologies Geographic Atrophy Treatment Product
Table 86. Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 87. Regenerative Patch Technologies Recent Development
Table 88. Roche Holding AG Company Detail
Table 89. Roche Holding AG Business Overview
Table 90. Roche Holding AG Geographic Atrophy Treatment Product
Table 91. Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 92. Roche Holding AG Recent Development
Table 93. Gensight Biologics SA Company Detail
Table 94. Gensight Biologics SA Business Overview
Table 95. Gensight Biologics SA Geographic Atrophy Treatment Product
Table 96. Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 97. Gensight Biologics SA Recent Development
Table 98. NGM Biopharmaceuticals Company Detail
Table 99. NGM Biopharmaceuticals Business Overview
Table 100. NGM Biopharmaceuticals Geographic Atrophy Treatment Product
Table 101. NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 102. NGM Biopharmaceuticals Recent Development
Table 103. AstraZeneca Company Detail
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Geographic Atrophy Treatment Product
Table 106. AstraZeneca Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 107. AstraZeneca Recent Development
Table 108. Lineage Cell Therapeutics Company Detail
Table 109. Lineage Cell Therapeutics Business Overview
Table 110. Lineage Cell Therapeutics Geographic Atrophy Treatment Product
Table 111. Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 112. Lineage Cell Therapeutics Recent Development
Table 113. Allergan Company Detail
Table 114. Allergan Business Overview
Table 115. Allergan Geographic Atrophy Treatment Product
Table 116. Allergan Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 117. Allergan Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geographic Atrophy Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Geographic Atrophy Treatment Market Share by Type: 2023 VS 2030
Figure 3. Late-stage (Phase III) Treatment Features
Figure 4. Phase II Treatment Features
Figure 5. Phase I Treatment Features
Figure 6. Pre-Clinical Stage Treatment Features
Figure 7. Global Geographic Atrophy Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Geographic Atrophy Treatment Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Geographic Atrophy Treatment Report Years Considered
Figure 12. Global Geographic Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Geographic Atrophy Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Geographic Atrophy Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Geographic Atrophy Treatment Market Share by Players in 2023
Figure 16. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Geographic Atrophy Treatment Revenue in 2023
Figure 18. North America Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 20. United States Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 24. Germany Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Geographic Atrophy Treatment Market Share by Region (2019-2030)
Figure 32. China Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 47. IVERIC bio Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 48. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 49. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 50. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 51. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 52. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 53. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 54. Roche Holding AG Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 55. Gensight Biologics SA Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 56. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 58. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 59. Allergan Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Geographic Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Late-stage (Phase III) Treatment
Table 3. Key Players of Phase II Treatment
Table 4. Key Players of Phase I Treatment
Table 5. Key Players of Pre-Clinical Stage Treatment
Table 6. Global Geographic Atrophy Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Geographic Atrophy Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Geographic Atrophy Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Geographic Atrophy Treatment Market Share by Region (2019-2024)
Table 10. Global Geographic Atrophy Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Geographic Atrophy Treatment Market Share by Region (2025-2030)
Table 12. Geographic Atrophy Treatment Market Trends
Table 13. Geographic Atrophy Treatment Market Drivers
Table 14. Geographic Atrophy Treatment Market Challenges
Table 15. Geographic Atrophy Treatment Market Restraints
Table 16. Global Geographic Atrophy Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Geographic Atrophy Treatment Market Share by Players (2019-2024)
Table 18. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2023)
Table 19. Ranking of Global Top Geographic Atrophy Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Geographic Atrophy Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Geographic Atrophy Treatment Product Solution and Service
Table 23. Date of Enter into Geographic Atrophy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Geographic Atrophy Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Geographic Atrophy Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Geographic Atrophy Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Geographic Atrophy Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Geographic Atrophy Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Geographic Atrophy Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Geographic Atrophy Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Geographic Atrophy Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Geographic Atrophy Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Apellis Pharmaceuticals Company Detail
Table 49. Apellis Pharmaceuticals Business Overview
Table 50. Apellis Pharmaceuticals Geographic Atrophy Treatment Product
Table 51. Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 52. Apellis Pharmaceuticals Recent Development
Table 53. IVERIC bio Company Detail
Table 54. IVERIC bio Business Overview
Table 55. IVERIC bio Geographic Atrophy Treatment Product
Table 56. IVERIC bio Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 57. IVERIC bio Recent Development
Table 58. Alkeus Pharmaceuticals Company Detail
Table 59. Alkeus Pharmaceuticals Business Overview
Table 60. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product
Table 61. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 62. Alkeus Pharmaceuticals Recent Development
Table 63. Hemera Biosciences Company Detail
Table 64. Hemera Biosciences Business Overview
Table 65. Hemera Biosciences Geographic Atrophy Treatment Product
Table 66. Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 67. Hemera Biosciences Recent Development
Table 68. Allegro Ophthalmics Company Detail
Table 69. Allegro Ophthalmics Business Overview
Table 70. Allegro Ophthalmics Geographic Atrophy Treatment Product
Table 71. Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 72. Allegro Ophthalmics Recent Development
Table 73. Stealth BioTherapeutics Company Detail
Table 74. Stealth BioTherapeutics Business Overview
Table 75. Stealth BioTherapeutics Geographic Atrophy Treatment Product
Table 76. Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 77. Stealth BioTherapeutics Recent Development
Table 78. Gyroscope Therapeutics Company Detail
Table 79. Gyroscope Therapeutics Business Overview
Table 80. Gyroscope Therapeutics Geographic Atrophy Treatment Product
Table 81. Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 82. Gyroscope Therapeutics Recent Development
Table 83. Regenerative Patch Technologies Company Detail
Table 84. Regenerative Patch Technologies Business Overview
Table 85. Regenerative Patch Technologies Geographic Atrophy Treatment Product
Table 86. Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 87. Regenerative Patch Technologies Recent Development
Table 88. Roche Holding AG Company Detail
Table 89. Roche Holding AG Business Overview
Table 90. Roche Holding AG Geographic Atrophy Treatment Product
Table 91. Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 92. Roche Holding AG Recent Development
Table 93. Gensight Biologics SA Company Detail
Table 94. Gensight Biologics SA Business Overview
Table 95. Gensight Biologics SA Geographic Atrophy Treatment Product
Table 96. Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 97. Gensight Biologics SA Recent Development
Table 98. NGM Biopharmaceuticals Company Detail
Table 99. NGM Biopharmaceuticals Business Overview
Table 100. NGM Biopharmaceuticals Geographic Atrophy Treatment Product
Table 101. NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 102. NGM Biopharmaceuticals Recent Development
Table 103. AstraZeneca Company Detail
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Geographic Atrophy Treatment Product
Table 106. AstraZeneca Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 107. AstraZeneca Recent Development
Table 108. Lineage Cell Therapeutics Company Detail
Table 109. Lineage Cell Therapeutics Business Overview
Table 110. Lineage Cell Therapeutics Geographic Atrophy Treatment Product
Table 111. Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 112. Lineage Cell Therapeutics Recent Development
Table 113. Allergan Company Detail
Table 114. Allergan Business Overview
Table 115. Allergan Geographic Atrophy Treatment Product
Table 116. Allergan Revenue in Geographic Atrophy Treatment Business (2019-2024) & (US$ Million)
Table 117. Allergan Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geographic Atrophy Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Geographic Atrophy Treatment Market Share by Type: 2023 VS 2030
Figure 3. Late-stage (Phase III) Treatment Features
Figure 4. Phase II Treatment Features
Figure 5. Phase I Treatment Features
Figure 6. Pre-Clinical Stage Treatment Features
Figure 7. Global Geographic Atrophy Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Geographic Atrophy Treatment Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Geographic Atrophy Treatment Report Years Considered
Figure 12. Global Geographic Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Geographic Atrophy Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Geographic Atrophy Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Geographic Atrophy Treatment Market Share by Players in 2023
Figure 16. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Geographic Atrophy Treatment Revenue in 2023
Figure 18. North America Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 20. United States Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 24. Germany Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Geographic Atrophy Treatment Market Share by Region (2019-2030)
Figure 32. China Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Geographic Atrophy Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Geographic Atrophy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 47. IVERIC bio Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 48. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 49. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 50. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 51. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 52. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 53. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 54. Roche Holding AG Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 55. Gensight Biologics SA Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 56. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 58. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 59. Allergan Revenue Growth Rate in Geographic Atrophy Treatment Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232